Fulton Breakefield Broenniman’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-51,521
| Closed | -$3.36M | – | 113 |
|
|
2016
Q4 | $3.36M | Sell |
51,521
-1,714
| -3% | -$112K | 0.67% | 58 |
|
|
2016
Q3 | $3.77M | Buy |
53,235
+387
| +0.7% | +$27.4K | 0.76% | 56 |
|
|
2016
Q2 | $3.91M | Buy |
52,848
+1,342
| +3% | +$99.2K | 0.8% | 55 |
|
|
2016
Q1 | $3.34M | Buy |
51,506
+3,422
| +7% | +$222K | 0.73% | 55 |
|
|
2015
Q4 | $3.71M | Buy |
48,084
+1,350
| +3% | +$104K | 0.82% | 52 |
|
|
2015
Q3 | $3.85M | Sell |
46,734
-1,279
| -3% | -$105K | 0.91% | 51 |
|
|
2015
Q2 | $4.23M | Buy |
48,013
+1,668
| +4% | +$147K | 0.93% | 50 |
|
|
2015
Q1 | $4.1M | Buy |
46,345
+1,551
| +3% | +$137K | 0.91% | 47 |
|
|
2014
Q4 | $3.72M | Buy |
44,794
+859
| +2% | +$71.3K | 0.81% | 51 |
|
|
2014
Q3 | $3.71M | Buy |
43,935
+1,126
| +3% | +$95K | 0.87% | 50 |
|
|
2014
Q2 | $3.47M | Sell |
42,809
-1,087
| -2% | -$88.2K | 0.84% | 49 |
|
|
2014
Q1 | $3.34M | Buy |
43,896
+1,376
| +3% | +$105K | 0.86% | 48 |
|
|
2013
Q4 | $3.06M | Buy |
42,520
+1,431
| +3% | +$103K | 0.81% | 48 |
|
|
2013
Q3 | $2.82M | Buy |
41,089
+1,602
| +4% | +$110K | 0.76% | 48 |
|
|
2013
Q2 | $2.5M | Buy |
+39,487
| New | +$2.5M | 0.73% | 52 |
|